## Note
nid: 1497716047671
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step1_v11::#NBME::20, #AK_Step1_v11::#OME_banner::Clinical::16_Surgery:_Subspecialty::08_Vascular, #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::1surgery, #AK_Step2_v11::!Shelf::FM::no_dupes, #AK_Step2_v11::!Shelf::FM::no_dupes::only_step2, #AK_Step2_v11::!Shelf::IM::no_dupes, #AK_Step2_v11::!Shelf::IM::no_dupes::only_step2, #AK_Step2_v11::!Shelf::Surgery::no_dupes, #AK_Step2_v11::!Shelf::Surgery::no_dupes::only_step2, #AK_Step2_v11::#AMBOSS, #AK_Step2_v11::#AMBOSS::Surgery, #AK_Step2_v11::#B&B::01_Cardiology::Other::Perph_Vascular_Diseases, #AK_Step2_v11::#OME::16_Surgical_Subspecialties::06_CT, #AK_Step2_v11::#Resources_by_rotation::FM::ome::surg::ctsurg_aorta_vascular, #AK_Step2_v11::#Resources_by_rotation::IM::uw::cardio::cardio_dorian, #AK_Step2_v11::#Resources_by_rotation::IM::uw::cardio::cardio_zanki, #AK_Step2_v11::#Resources_by_rotation::Surgery::ome::subspecialty::ctsurg_aorta_vascular, #AK_Step2_v11::#Subjects::Cardiology::12_Vascular_Pathology::Peripheral_Vascular_Pathology::Peripheral_Artery_Disease, #AK_Step2_v11::#Subjects::Cardiology::12_Vascular_Pathology::Peripheral_Vascular_Pathology::Peripheral_Artery_Disease::Management, #AK_Step2_v11::#UWorld::1000-9999::8000-8999::8928, #AK_Step2_v11::Original_decks::Dorian::fam::ome::surg::ctsurg_aorta_vascular, #AK_Step2_v11::Original_decks::Dorian::im::uw::cardio, #AK_Step2_v11::Original_decks::Dorian::surg::ome::subspecialty::ctsurg_aorta_vascular, #AK_Step2_v11::Original_decks::Zanki_Step_2::IM::Cardio
markdown: false

### Text
What is the <i>most useful intervention</i> to <b>improve
functional capacity</b> and <b>reduce symptomatic claudication</b>
in patients with <u>peripheral artery disease</u>?
<div>
  {{c1::Supervised graded exercise program}}
</div>

### Extra
<i>patients should also be started on low-dose <b>aspirin</b> and a
<b>statin</b>; <b>cilostazol</b> and percutaneous or surgical
revascularization may be considered for those with
<b><u>persistent</u></b> sympotms</i>
<div><img src="paste-772054731194890.jpg" class="resizer"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/surgery-subspecialty/vascular/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_2.png"></a>
</div>

### Additional Resources
<i><b>Definition</b>: The patient walks to the point of
claudication, then continues for another cycle after a short rest.
Recommended for 30-40 minutes 3-5 times a week. Will increase
walking distance by improving endothelial function.</i>
<div>
  <i>Initial management of PAD is <b>conservative</b>: stop
  <b>smoking</b>, be started on anti-platelet like <b>aspirin</b>
  and a <b>statin</b>; pharmacologic therapy with <b>cilostazol</b>
  and percutaneous or surgical revascularization may be considered
  for those with persistent sympotms</i>
</div>
<div>
  <div>
    <div>
      <i><img src="paste-5056679745945601.jpg" class="resizer"
      style="width: 782px;"></i>
    </div>
  </div>
  <div>
    <div>
      <i><img src="paste-4994239511396353.jpg" class="resizer"
      style="width: 782px;"></i>
    </div>
  </div>
</div><img src="paste-362332031025153.jpg" class="resizer">

### One by one

